You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mecasermin

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

22q13 Deletion Syndrome, Phelan-McDermid Syndrome Trial in New York (Insulin-Like Growth Factor-1 (IGF-1), Normal saline)

Completed
Has Results
  • 22q13 Deletion Syndrome
  • Phelan-McDermid Syndrome
  • Insulin-Like Growth Factor-1 (IGF-1)
  • Normal saline
  • New York, New York
    Seaver Austin Center, Icahn School of Medicine at Mount Sinai
Apr 18, 2022

Anorexia Nervosa Trial in Boston (RhIGF-1 with transdermal 17-beta estradiol, Placebo and transdermal 17-beta estradiol)

Completed
Has Results
  • Anorexia Nervosa
  • RhIGF-1 with transdermal 17-beta estradiol
  • Placebo and transdermal 17-beta estradiol
  • Boston, Massachusetts
    Massachusetts General Hospital
Jun 22, 2021

Primary Insulin-like Growth Factor-1 Deficiency Trial in Basking Ridge (mecasermin [rDNA origin] injection)

Terminated
  • Primary Insulin-like Growth Factor-1 Deficiency
  • mecasermin [rDNA origin] injection
  • Basking Ridge, New Jersey
    Ipsen Central Contact
Nov 4, 2020

Duchenne Muscular Dystrophy Trial in Cincinnati (IGF-1)

Completed
Has Results
  • Duchenne Muscular Dystrophy
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Dec 28, 2020

Retinopathy of Prematurity (ROP) Trial in Worldwide (rhIGF-1/rhIGFBP-3)

Completed
Has Results
  • Retinopathy of Prematurity (ROP)
  • Mobile, Alabama
  • +15 more
Apr 26, 2022

Growth Disorders Trial in Paris (rh IGF-1 (mecasermin))

Terminated
Has Results
  • Growth Disorders
  • rh IGF-1 (mecasermin)
  • Paris, France
    Ipsen
Aug 5, 2020

Insulin-Like Growth Factor-1 Deficiency, Growth Disorders Trial in Brisbane (rhIGF-1 (mecasermin) for a period of 86 weeks)

Completed
Has Results
  • Insulin-Like Growth Factor-1 Deficiency
  • Growth Disorders
  • rhIGF-1 (mecasermin) for a period of 86 weeks
  • Brisbane, California
    Ipsen
Jul 7, 2020

Insulin-like Growth Factor-1 Deficiency Trial in Brisbane (NutropinAq® (Somatropin [rDNA origin]), Increlex® (Mecasermin [rDNA

Terminated
Has Results
  • Insulin-like Growth Factor-1 Deficiency
  • NutropinAq® (Somatropin [rDNA origin])
  • Increlex® (Mecasermin [rDNA origin] injection) + NutropinAq® (Somatropin [rDNA origin])
  • Brisbane, California
    Ipsen
Sep 5, 2019

Retinopathy of Prematurity (ROP), Intraventricular Hemorrhage, Bronchopulmonary Dysplasia Trial in Worldwide (SHP607)

Active, not recruiting
  • Retinopathy of Prematurity (ROP)
  • +3 more
  • Mobile, Alabama
  • +50 more
Mar 21, 2022

Growth Disorders, Insulin-Like Growth Factor-1 Deficiency Trial in Brisbane (rhIGF-1 (mecasermin, Tercica, Inc.))

Completed
Has Results
  • Growth Disorders
  • Insulin-Like Growth Factor-1 Deficiency
  • rhIGF-1 (mecasermin, Tercica, Inc.)
  • Brisbane, California
    Ipsen (formerly Tercica)
Sep 5, 2019

IGF1 Deficiency Trial in Worldwide (Increlex®)

Recruiting
  • IGF1 Deficiency
  • Miami, Florida
  • +50 more
Dec 29, 2022

Short Stature Trial (Increlex)

Active, not recruiting
  • Short Stature
  • (no location specified)
Oct 14, 2022

Anorexia Nervosa Trial in Boston (RhIGF-1)

Completed
Has Results
  • Anorexia Nervosa
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 22, 2021

Disorder of Bone Density and Structure, Unspecified Trial in Boston (Recombinant human insulin like growth factor-1 (rhIGF-1))

Completed
Has Results
  • Disorder of Bone Density and Structure, Unspecified
  • Recombinant human insulin like growth factor-1 (rhIGF-1)
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 22, 2021

Growth Hormone Insensitivity Syndrome Trial in Brisbane (mecasermin)

Completed
  • Growth Hormone Insensitivity Syndrome
  • mecasermin
  • Brisbane, California
    Ipsen
Jan 4, 2019

Rare Diseases Clinical Research Network: Neurophysiological

Completed
  • Rett Syndrome, Preserved Speech Variant
  • +2 more
  • Auditory and Visual Event-related Potentials and EEG
  • Denver, Colorado
  • +4 more
Aug 3, 2021

Rett Syndrome Trial in Boston (Recombinant Human Insulin Growth Factor 1 (rhIGF-1), Placebo)

Completed
Has Results
  • Rett Syndrome
  • Recombinant Human Insulin Growth Factor 1 (rhIGF-1)
  • Placebo
  • Boston, Massachusetts
    Boston Children's Hospital
Mar 23, 2018

Rett Syndrome Trial in Worldwide (Sarizotan low dose, Sarizotan high dose, Placebo)

Terminated
Has Results
  • Rett Syndrome
  • Sarizotan low dose
  • +2 more
  • Birmingham, Alabama
  • +13 more
Nov 22, 2021

Measure for Rett Syndrome (RettBe)

Completed
  • Rett Syndrome
    • Tampa, Florida
      University of South Florida
    Dec 8, 2020

    Rett Syndrome Trial in Boston (rhIGF-1)

    Completed
    Has Results
    • Rett Syndrome
    • Boston, Massachusetts
      Boston Children's Hospital
    Jun 20, 2017

    Heart Failure, Myocardial Infarction Trial in Cork, Leiden (mecasermin, 0.9% sodium chloride injection)

    Completed
    • Heart Failure
    • Myocardial Infarction
    • mecasermin
    • 0.9% sodium chloride injection
    • Cork, Ireland
    • +1 more
    Mar 28, 2017

    Crohn Disease Trial in Columbus (rhIGF (Increlex))

    Terminated
    Has Results
    • Crohn Disease
    • rhIGF (Increlex)
    • Columbus, Ohio
      Nationwide Children's Hospital
    Feb 23, 2018

    HIV Lipodystrophy Trial in Dallas (mecasermin, Placebo control)

    Terminated
    • HIV Lipodystrophy
    • mecasermin
    • Placebo control
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Mar 22, 2016

    Growth Failure, Chronic Liver Disease Trial (Increlex)

    Withdrawn
    • Growth Failure
    • Chronic Liver Disease
    • (no location specified)
    Jul 12, 2016

    Growth Failure, X-linked Severe Combined Immunodeficiency (XSCID), Growth Hormone Resistence Trial run by the NIAID (Increlex)

    Terminated
    Has Results
    • Growth Failure
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 2, 2015